Strs Ohio cut its position in shares of Natera, Inc. (NASDAQ:NTRA) by 10.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 54,600 shares of the medical research company’s stock after selling 6,200 shares during the quarter. Strs Ohio owned about 0.10% of Natera worth $703,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NTRA. Capital World Investors boosted its holdings in Natera by 0.8% in the second quarter. Capital World Investors now owns 4,222,609 shares of the medical research company’s stock worth $45,858,000 after acquiring an additional 32,000 shares in the last quarter. Jennison Associates LLC boosted its holdings in Natera by 1.0% in the second quarter. Jennison Associates LLC now owns 2,356,346 shares of the medical research company’s stock worth $25,590,000 after acquiring an additional 23,473 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Natera by 12.6% in the second quarter. Vanguard Group Inc. now owns 2,261,052 shares of the medical research company’s stock worth $24,555,000 after acquiring an additional 253,344 shares in the last quarter. Macquarie Group Ltd. boosted its holdings in Natera by 112.3% in the second quarter. Macquarie Group Ltd. now owns 1,061,880 shares of the medical research company’s stock worth $11,532,000 after acquiring an additional 561,659 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Natera by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 634,743 shares of the medical research company’s stock worth $6,893,000 after acquiring an additional 9,223 shares in the last quarter. Institutional investors own 59.89% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Strs Ohio Reduces Position in Natera, Inc. (NTRA)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/08/strs-ohio-reduces-position-in-natera-inc-ntra.html.

In other news, insider Jonathan Sheena sold 120,000 shares of the company’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $12.54, for a total transaction of $1,504,800.00. Following the transaction, the insider now directly owns 533,208 shares of the company’s stock, valued at $6,686,428.32. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 12.57% of the company’s stock.

Several equities research analysts have commented on the company. Zacks Investment Research raised Natera from a “sell” rating to a “buy” rating and set a $9.25 target price on the stock in a report on Thursday, August 10th. ValuEngine raised Natera from a “strong sell” rating to a “sell” rating in a report on Thursday, August 10th. Cowen and Company reaffirmed a “buy” rating and set a $14.00 price target on shares of Natera in a report on Friday, September 1st. BidaskClub downgraded Natera from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Finally, Morgan Stanley lowered their price target on Natera from $18.00 to $13.00 and set an “overweight” rating on the stock in a report on Monday, August 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $16.20.

Natera, Inc. (NASDAQ NTRA) opened at $10.79 on Wednesday.

Natera (NASDAQ:NTRA) last announced its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.52). The firm had revenue of $53.60 million for the quarter, compared to the consensus estimate of $50.57 million. Natera had a negative return on equity of 137.46% and a negative net margin of 62.64%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the company posted ($0.46) earnings per share. sell-side analysts anticipate that Natera, Inc. will post -2.02 earnings per share for the current fiscal year.

Natera Company Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Stock Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related stocks with our FREE daily email newsletter.